Piper Sandler Downgrades IO Biotech to Neutral from Overweight, PT to $0.5.

lunes, 26 de enero de 2026, 1:16 pm ET1 min de lectura
IOBT--

Piper Sandler Downgrades IO Biotech to Neutral from Overweight, PT to $0.5.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios